Screener
Mirum Pharmaceuticals, Inc. MIRM Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $262.68M+39.4% | $261.46M+43.5% | $254.38M+25.3% | $230.14M+17.5% | $188.37M-9.7% | ||
| $107.56M+40.7% | $61.35M-6.8% | $86.64M+49.9% | $93.53M+52.1% | $76.43M+69.4% | ||
| $145.36M+36.1% | $133.11M+38.9% | $123.33M+57.5% | $107.13M+56.3% | $106.84M+76.8% | ||
| $25.77M+12.3% | $25.52M+13.8% | $24.89M+11.1% | $24.02M+11.2% | $22.94M+12.2% | ||
| $636.31M+40.3% | $569.44M+38.6% | $549.68M+39.9% | $530.58M+37.2% | $453.4M+23.3% | ||
| $2.25M+91.2% | $2.41M+118% | $1.86M+63.5% | $1.28M+5.4% | $1.18M+6.9% | ||
| $247.39M+4.0% | $254.15M+4.2% | $260.92M+4.4% | $231.9M-9.3% | $237.87M-9.1% | ||
| $1.04B+44.0% | $890.92M+29.1% | $842.81M+25.7% | $785.12M+17.6% | $725.83M+9.8% | ||
| $23.43M+32.7% | $59.4M+410% | $9.61M-34.2% | $12.17M+27.5% | $17.66M+79.4% | ||
| $222.79M+53.9% | $272.82M+114% | $205.8M+62.6% | $160.36M+38.5% | $144.8M+28.9% | ||
| $1.06B+124% | $648.42M+41.9% | $528.12M+18.6% | $493.07M+13.1% | $470.67M+9.0% | ||
| 200M0.0% | 200M0.0% | 200M+3,999,900% | 200M0.0% | 200M0.0% | ||
| -$1.52B-129% | -$1.46B-121% | -$667.54M-3.6% | -$661.81M-6.7% | -$664.72M-9.7% | ||
| -$10.42M-104% | $242.49M+4.0% | $314.69M+39.5% | $292.05M+25.9% | $255.16M+11.4% | ||
| $1.04B+44.0% | $890.92M+29.1% | $842.81M+25.7% | $785.12M+17.6% | $725.83M+9.8% |
FAQ
- What are Mirum Pharmaceuticals, Inc.'s total assets?
- Mirum Pharmaceuticals, Inc. (MIRM) holds $1.0B in total assets, up 44.0% year over year.
- How much debt does Mirum Pharmaceuticals, Inc. have?
- Mirum Pharmaceuticals, Inc. carries $12.9M in total debt against -$10.4M of shareholders' equity, a debt-to-equity ratio of 0.06.
- How much cash does Mirum Pharmaceuticals, Inc. have?
- Mirum Pharmaceuticals, Inc. holds $262.7M in cash and equivalents.
- Can Mirum Pharmaceuticals, Inc. cover its short-term obligations?
- Its current ratio is 2.86 — current assets exceed current liabilities.
- Where does Mirum Pharmaceuticals, Inc.'s balance sheet data come from?
- Every line is extracted from Mirum Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
